SCHEMBL6233350

SCHEMBL6233350

CCC(C1CCCN1)N(CC1CCCCC1)c1nc(N)nc(Oc2ccc(N)cc2F)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6429669 0.88 MEN1 (0.34)
SCHEMBL5550424 0.83 MEN1 (0.32)
SCHEMBL5549892 0.78 GALR1 (0.44)
SCHEMBL6612957 0.76 HTR2A (0.38)
SCHEMBL6231144 0.74 SIGMAR1 (0.31)
SCHEMBL5033937 0.73 GALR1 (0.34)
SCHEMBL6427921 0.70
SCHEMBL6268764 0.70 GALR1 (0.40)
SCHEMBL6607370 0.69 GALR1 (0.39)
SCHEMBL5554034 0.68 GALR1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560817-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS Reddy US Therapeutics, Inc. (US) 2005-08-10 EP claimed
WO-2004026844-A1 METHODS AND COMPOSITIONS OF NOVEL TRIAZINE COMPOUNDS REDDY US THERAPEUTICS, INC. (US) 2004-04-01 WO claimed